BSH18_Chris Response to CAR T-cell treatment in CLL patients
Patients with advanced chronic lymphocytic leukemia (CLL) don't respond well to chimeric antigen receptor (CAR) T-cell therapy. In this interview, Chris Fegan, MB, MD, FRCP, FRCPath, from Cardiff Univ...
Author: VJHemOnc
Added: 07/24/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts